Board Director Jeffrey Rhodes Resigns Effective Immediately
Leadership changes affect how a company is managed and can impact investor confidence in governance.
LifeStance Health Group, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 5 Aug 2026Leadership changes affect how a company is managed and can impact investor confidence in governance.
Director elections determine who oversees the company; shareholders vote on leadership every year.
New stock sale dilutes existing shareholders but raises cash the company can use to grow.
Official document explains the terms of a new stock sale to help investors understand the deal.
Official document explains the terms of a new stock sale to help investors understand the deal.
Quarterly earnings show whether the company is making money and growing or struggling.
Quarterly earnings show whether the company is making money and growing or struggling.
Stocky reads LifeStance Health Group, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
LifeStance Health Group, Inc.'s most recent tracked filing was a 8-K on 7 Jul 2026: Board Director Jeffrey Rhodes Resigns Effective Immediately.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 5 Aug 2026.